Wednesday, July 2, 2025

Ventripoint Installs First VMS+3.0 At Renowned US Cancer Hospital

Ventripoint Diagnostics (TSXV: VPT) this morning announced that it has installed its first VMS+3.0 whole-heart analysis system into a US hospital. The device was installed at the University of Texas MD Anderson Cancer Center, one of the worlds most respected centers focused entirely on cancer. The facility has been ranked one of the top two hospitals for cancer every year for thirty consecutive years.

While being the first device installed in the United States, it was also the first device to be installed remotely, demonstrating the universality of the installation process. This is a key feature given current global restrictions as a result of the ongoing pandemic, as it does not limit the company in terms of revenue generation, nor in terms of deploying additional devices to assist in patient care.

Furthermore, the devices bound for the US have had a key modification in that they are fitted with a workstation. This change enables remote analysis of the echocardiogram to be conducted by the cardiologist, after the ultrasound has been conducted by a sonographer. This enables a viewing room to be utilized by the cardiologist, whereas the European tradition is for the cardiologist to conduct the entire appointment. The modifications enable hospitals to maximize patient throughput, lowering the barriers to adoption for the device across North America.

The company has maintained its estimate calling for 40,000+ VMS+3.0 devices being required to diagnose and monitor patients with heart conditions in North America and Europe. These estimates do not include the potential uses in the face of COVID-19, and the impacts that the disease is believed to have long-term on the condition of the heart.

Ventripoint Diagnostics last traded at $0.14 on the TSX Venture.


FULL DISCLOSURE: Ventripoint Diagnostics is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Ventripoint Diagnostics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Ventripoint Enters Collaboration Agreement To Test Echocardiology Technology For Use With Canines

Ventripoint Diagnostics (TSXV: VPT) has entered into a new collaboration agreement as of this morning....

Monday, January 11, 2021, 09:21:12 AM

Ventripoint Installs Whole Heart Analysis System At Toronto General Hospital

Ventripoint Diagnostics (TSXV: VPT) has seen its technology installed at the largest cardiac centre in...

Thursday, November 5, 2020, 10:47:10 AM

Ventripoint Joint Venture Begins Device Certification For Use In Covid Patients In China

Ventripoint Diagnostics (TSXV: VPT) is progressing with its joint venture partner in China. This morning...

Tuesday, March 16, 2021, 09:29:18 AM

Ventripoint Diagnostics Installs Whole Heart Analysis Device At Leading European Hospital

Ventripoint Diagnostics (TSXV: VPT) this morning announced that its latest version of its whole heart...

Monday, September 28, 2020, 09:09:32 AM

Providing Echocardiography For Companion Animals – The Daily Dive feat George Adams of Ventripoint

Today on the Daily Dive is that of George Adams, CEO of Ventripoint Diagnostics (TSXV:...

Thursday, January 28, 2021, 01:30:00 PM